Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer

por Oshima, Kotoe, Hirano, Hidekazu, Shoji, Hirokazu, Iwasa, Satoru, Okita, Natsuko, Takashima, Atsuo, Boku, Narikazu
Publicado 2022

Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection

por Shoji, Hirokazu, Yamada, Yasuhide, Taniguchi, Hirokazu, Nagashima, Kengo, Okita, Natsuko, Takashima, Atsuo, Honma, Yoshitaka, Iwasa, Satoru, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro
Publicado 2014

Esophageal Metastasis from Rectal Cancer Successfully Treated with Fluorouracil-Based Chemotherapy with Bevacizumab: A Case Report and Review of the Literature

por Watanabe, Sho, Takashima, Atsuo, Taniguchi, Hirokazu, Tanaka, Yusaku, Nakamura, Shoko, Okita, Natsuko, Honma, Yoshitaka, Iwasa, Satoru, Kato, Ken, Hamaguchi, Tetsuya, Boku, Narikazu
Publicado 2017

Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy

por Tamura, Nobumasa, Honma, Yoshitaka, Sekine, Shigeki, Tsukamoto, Shunsuke, Hirano, Hidekazu, Okita, Natsuko, Shoji, Hirokazu, Iwasa, Satoru, Takashima, Atsuo, Kato, Ken, Boku, Narikazu
Publicado 2020

Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer

por Takamizawa, Shigemasa, Shoji, Hirokazu, Hirano, Hidekazu, Izutsu, Koji, Yamamoto, Shun, Iwasa, Satoru, Honma, Yoshitaka, Okita, Natsuko, Takashima, Atsuo, Kato, Ken, Boku, Narikazu
Publicado 2021

Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies

por Takahashi, Naoki, Iwasa, Satoru, Taniguchi, Hirokazu, Sasaki, Yusuke, Shoji, Hirokazu, Honma, Yoshitaka, Takashima, Atsuo, Okita, Natsuko, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro, Yamada, Yasuhide
Publicado 2016

Promotion of the Warburg effect is associated with poor benefit from adjuvant chemotherapy in colorectal cancer

por Kitazawa, Masashi, Hatta, Tomohisa, Sasaki, Yusuke, Fukui, Kazuhiko, Ogawa, Koji, Fukuda, Eriko, Goshima, Naoki, Okita, Natsuko, Yamada, Yasuhide, Nakagama, Hitoshi, Natsume, Tohru, Horimoto, Katsuhisa
Publicado 2020

Progression patterns and site‐specific responses in advanced gastric cancer patients treated with nivolumab

por Kadono, Toru, Iwasa, Satoru, Nagashima, Kengo, Oshima, Kotoe, Yamamoto, Shun, Hirano, Hidekazu, Okita, Natsuko, Shoji, Hirokazu, Honma, Yoshitaka, Takashima, Atsuo, Kato, Ken, Ushijima, Toshikazu, Boku, Narikazu
Publicado 2023

Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastr...

por Takahashi, Naoki, Furuta, Koh, Taniguchi, Hirokazu, Sasaki, Yusuke, Shoji, Hirokazu, Honma, Yoshitaka, Iwasa, Satoru, Okita, Natsuko, Takashima, Atsuo, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro, Yamada, Yasuhide
Publicado 2015

Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer

por Aoki, Masahiko, Shoji, Hirokazu, Nagashima, Kengo, Imazeki, Hiroshi, Miyamoto, Takahiro, Hirano, Hidekazu, Honma, Yoshitaka, Iwasa, Satoru, Okita, Natsuko, Takashima, Atsuo, Kato, Ken, Higuchi, Kazuhide, Boku, Narikazu
Publicado 2019

Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)

por Iwasa, Satoru, Okita, Natsuko, Kuchiba, Aya, Ogawa, Gakuto, Kawasaki, Mamiko, Nakamura, Kenichi, Shoji, Hirokazu, Honma, Yoshitaka, Takashima, Atsuo, Kato, Ken, Hamaguchi, Tetsuya, Boku, Narikazu, Yamada, Yasuhide
Publicado 2020

Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer

por Takahashi, Naoki, Yamada, Yasuhide, Furuta, Koh, Nagashima, Kengo, Kubo, Akiko, Sasaki, Yusuke, Shoji, Hirokazu, Honma, Yoshitaka, Iwasa, Satoru, Okita, Natsuko, Takashima, Atsuo, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro
Publicado 2015

Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study

por Ishikawa, Masashi, Takashima, Atsuo, Nagata, Yusuke, Sawada, Ryoichi, Aoki, Masahiko, Imazeki, Hiroshi, Hirano, Hidekazu, Shoji, Hirokazu, Honma, Yoshitaka, Iwasa, Satoru, Okita, Natsuko, Kato, Ken, Saruta, Masayuki, Boku, Narikazu
Publicado 2021

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

por Masuda, Ken, Shoji, Hirokazu, Nagashima, Kengo, Yamamoto, Shun, Ishikawa, Masashi, Imazeki, Hiroshi, Aoki, Masahiko, Miyamoto, Takahiro, Hirano, Hidekazu, Honma, Yoshitaka, Iwasa, Satoru, Okita, Natsuko, Takashima, Atsuo, Kato, Ken, Boku, Narikazu
Publicado 2019

ACT-1 Multicenter investigator-initiated registration-directed Phase 2 study of E7090 in subjects with advanced or recurrent solid tumors with fibroblast growth factor receptor (FG...

por Takahashi, Masamichi, Chiba, Yohei, Sudo, Kazuki, Kojima, Yuki, Okuma, Hitomi, Kohsaka, Shinji, Ichimura, Masahiko, Okita, Natsuko, Nakamura, Kenichi, Machida, Ryunosuke, Kinoshita, Ichiro, Takahashi, Masanobu, Matsubara, Junichi, Kusaba, Hitoshi, Yonemori, Kan
Publicado 2021

Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy

por Tada, Kohei, Kitano, Shigehisa, Shoji, Hirokazu, Nishimura, Takashi, Shimada, Yasuhiro, Nagashima, Kengo, Honma, Yoshitaka, Iwasa, Satoru, Okita, Natsuko, Takashima, Atsuo, Kato, Ken, Yamada, Yasuhide, Katayama, Naoyuki, Boku, Narikazu, Hamaguchi, Tetsuya, Heike, Yuji
Publicado 2015

Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of repor...

por Watanabe, Sho, Honma, Yoshitaka, Murakami, Naoya, Igaki, Hiroshi, Mori, Taisuke, Hirano, Hidekazu, Okita, Natsuko, Shoji, Hirokazu, Iwasa, Satoru, Takashima, Atsuo, Kato, Ken, Kobayashi, Kenya, Matsumoto, Fumihiko, Yoshimoto, Seiichi, Itami, Jun, Boku, Narikazu
Publicado 2019

Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy

por Honma, Yoshitaka, Nagashima, Kengo, Hirano, Hidekazu, Shoji, Hirokazu, Iwasa, Satoru, Takashima, Atsuo, Okita, Natsuko, Kato, Ken, Boku, Narikazu, Murakami, Naoya, Inaba, Kouji, Ito, Yoshinori, Itami, Jun, Kanamori, Jun, Oguma, Junya, Daiko, Hiroyuki
Publicado 2019

A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUN...

por Chiba, Yohei, Sudo, Kazuki, Kojima, Yuki, Okuma, Hitomi, Kohsaka, Shinji, Machida, Ryunosuke, Ichimura, Masahiko, Anjo, Kenta, Kurishita, Kazumi, Okita, Natsuko, Nakamura, Kenichi, Kinoshita, Ichiro, Takahashi, Masanobu, Matsubara, Junichi, Kusaba, Hitoshi, Yonemori, Kan, Takahashi, Masamichi
Publicado 2022

Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma

por Hayashi, Hidetoshi, Arao, Tokuzo, Matsumoto, Kazuko, Kimura, Hideharu, Togashi, Yosuke, Hirashima, Yoshinori, Horita, Yosuke, Iwasa, Satoru, Okita, Natsuko Tsuda, Honma, Yoshitaka, Takashima, Atsuo, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro, Nakagawa, Kazuhiko, Nishio, Kazuto, Yamada, Yasuhide
Publicado 2014